Updated:
Terran Biosciences
Transforming the lives of patients with neurological and psychiatric illnesses | Terran is developing a broad portfolio of transformative therapeutics and...
Overview
Transforming the lives of patients with neurological and psychiatric illnesses | Terran is developing a broad portfolio of transformative therapeutics and technologies to change the lives of patients with neurological and psychiatric diseases.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Sector focus
Frequently asked questions
What investment stages does Terran Biosciences target?
Terran Biosciences targets early- to mid-stage clinical investments, primarily in neurology and psychiatry. The firm focuses on de-risking novel drug candidates from academic labs and early-stage biotechs, often through structured milestone-based capital deployment.
Which therapeutic areas does Terran Biosciences focus on?
The firm concentrates on neuroscience and psychiatric conditions, including schizophrenia, depression, neurodegenerative disorders, and other central nervous system (CNS) indications. This specialization sets it apart from more generalist biotech investors.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: